Microbot Medical Announces $13 Million Registered Direct Offering

Microbot Medical Inc. (NASDAQ: MBOT) recently disclosed its entry into Securities Purchase Agreements (the “Purchase Agreements”) with various investors, as per an 8-K filing with the Securities and Exchange Commission on February 9, 2025. Under the Registered Offering, Microbot Medical Inc., a Delaware corporation, agreed to issue and sell 6,103,289 shares of its common stock […]